Medicare Enrolled

Dr. John Burk, MD

Pulmonary Disease · Fort Worth, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
1201 FAIRMOUNT AVE, Fort Worth, TX 76104
8173355288
In practice since 2005 (20 years)
NPI: 1700871019 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Burk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Burk? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Burk

Dr. John Burk is a pulmonary disease in Fort Worth, TX, with 20 years in practice. Based on federal Medicare data, Dr. Burk performed 1,003 Medicare services across 663 unique beneficiaries.

Between the years covered by Open Payments, Dr. Burk received a total of $16,762 from 50 pharmaceutical and/or device companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Burk is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 48% volume in TX$ $16,762 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,003
Medicare services
Top 48% in TX for pulmonary disease
663
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~50 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity315$94$260
Hospital follow-up visit, moderate complexity302$63$181
Initial hospital admission, high complexity72$138$505
Office visit, established patient (30-39 min)61$93$270
Critical care, first 30-74 min41$169$555
Office visit, established patient (20-29 min)36$65$185
Hospital follow-up visit, low complexity18$39$104
Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope17$118$1,120
Test to measure expiratory airflow and volume changes before and after medication administration16$29$155
Computer-assisted image-guided navigation of lung airways using an endoscope15$75$2,125
Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes15$132$1,500
Test to determine lung volumes using sensors15$41$135
Test to examine how well the lungs exchange gases15$42$250
Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound14$52$140
Test to measure oxygen level in blood using ear or finger device continuously overnight14$20$65
Biopsy of lobe of lung using an endoscope, 1 lobe13$42$800
New patient office visit (45-59 min)13$113$410
Biopsy of lung airway using an endoscope11$35$545
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,762
Total received (2018-2024)
Avg $2,395/year across 7 years
Top 13% in TX for pulmonary disease
50
Companies
250
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$10,404 (62.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,358 (37.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$383
2023
$1,965
2022
$2,436
2021
$4,111
2020
$5,271
2019
$2,107
2018
$490

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Intuitive Surgical, Inc.
$13,130
GlaxoSmithKline, LLC.
$669
Novartis Pharmaceuticals Corporation
$304
Mylan Specialty L.P.
$262
AstraZeneca Pharmaceuticals LP
$207
Boehringer Ingelheim Pharmaceuticals, Inc.
$160
Sunovion Pharmaceuticals Inc.
$147
Baxter Healthcare
$145
Advanced Respiratory, Inc
$144
ADVANCED RESPIRATORY, INC
$115
Shionogi Inc
$94
Grifols USA, LLC
$81
Amgen Inc.
$77
GENZYME CORPORATION
$67
JAZZ PHARMACEUTICALS INC.
$65
Harmony Biosciences LLC
$63
Merck Sharp & Dohme LLC
$54
Merck Sharp & Dohme Corporation
$53
Takeda Pharmaceuticals U.S.A., Inc.
$51
Regeneron Healthcare Solutions, Inc.
$50
PFIZER INC.
$46
Allergan, Inc.
$43
ABBVIE INC.
$42
SANOFI-AVENTIS U.S. LLC
$38
Philips Electronics North America Corporation
$37
Jazz Pharmaceuticals Inc.
$37
Tactile Systems Technology Inc
$36
Gilead Sciences, Inc.
$36
ABIOMED
$35
Potrero Medical, Inc.
$33
Genentech USA, Inc.
$33
Janssen Pharmaceuticals, Inc
$32
Actelion Pharmaceuticals US, Inc.
$32
Itamar Medical Inc
$31
Body Vision Medical Inc.
$28
Covis Pharma GmBH
$27
La Jolla Pharmaceutical Company
$25
United Therapeutics Corporation
$23
Fisher & Paykel Healthcare Inc
$21
VERTEX PHARMACEUTICALS INCORPORATED
$20
INOGEN, INC.
$20
AbbVie Inc.
$20
Insmed, Inc.
$18
Ethicon US, LLC
$18
MAYNE PHARMA INC.
$16
Allergan Inc.
$16
Shire North American Group Inc
$15
Teva Pharmaceuticals USA, Inc.
$15
VIVUS, Inc.
$15
Veran Medical Technologies, Inc.
$14
Top 3 companies account for 84.1% of total payments
Associated products mentioned in payments ›
(7999) SRC Und · 400476/Simplus Full Face Mask- Medium · ANORO · AREXVY · AVYCAZ · Arikayce · BREO · BREZTRI · BROVANA · CHANTIX · DALVANCE · DIFICID · DUPIXENT · Da Vinci Surgical System · ELIQUIS · Esbriet · FASENRA · Fetroja · Flexitouch Plus · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · ION · Impella · LINX Reflux Management System · LONHALA MAGNAIR · Life 2000 Ventilation System · LungVision · NUCALA · OFEV · Prolastin-C Liquid · QSYMIA · SUNOSI · SYMBICORT · Spin · TEFLARO · TEZSPIRE · TOBI PODHALER · TOBI Podhaler · TOLSURA · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · WAKIX · Wakix · WatchPAT · Wellcentive Undiv · XARELTO · XOLAIR · XYWAV · Xyrem · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (62%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $1,671 per 100 Medicare services performed
Looking for a pulmonary disease in Fort Worth?
Compare pulmonary diseases in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
27
Per 100K population
1.3
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Burk is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 13%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Burk experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Burk performed 315 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Burk receive payments from pharmaceutical companies?
Yes. Dr. Burk received a total of $16,762 from 50 companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Burk's costs compare to other pulmonary diseases in Fort Worth?
Dr. Burk's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Burk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →